Effect of therapeutic regimens and polypharmacy on health-related quality of life of people with multiple myeloma: a cross-sectional study in Belo Horizonte, Brazil.

Jéssica Soares Malta Paula Lana de Miranda Drummond Lívia Pena Silveira Naiane Lima Costa Roberta Márcia Marques Dos Santos Carla Jorge Machado Adriano Max Moreira Reis Cristiane Aparecida Menezes de Pádua

Published in: Current medical research and opinion (2022)

We identified an independent association between HRQoL and polypharmacy in MM patients. However, there was no difference between the evaluated regimens, suggesting they are equivalent in Brazil about HRQoL.

Keyphrases

end stage renal disease
multiple myeloma
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
physical activity
peritoneal dialysis
emergency department
risk factors
adverse drug
patient reported outcomes